Stocks to Watch: Kezar, Avita, VirnetX

Dow Jones
2025/10/17
 

By Katherine Hamilton

 

Kezar Life Sciences plans to restructure and explore strategic alternatives. Shares soared 44% to $6.03 in after-hours trading Thursday.

Avita Medical shared preliminary revenue below expectations and said its CEO is stepping down. The stock shed 20% to $4.30 after the bell.

VirnetX got a long-term contract to provide cybersecurity to the U.S. Government. The stock gained 13% to $19.25.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

October 16, 2025 19:42 ET (23:42 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10